IONTOPHORESIS OF POLYPEPTIDES - EFFECT OF ETHANOL PRETREATMENT OF HUMAN SKIN

被引:73
作者
SRINIVASAN, V [1 ]
SU, MH [1 ]
HIGUCHI, WI [1 ]
BEHL, CR [1 ]
机构
[1] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
关键词
D O I
10.1002/jps.2600790708
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This paper explores the possibility of iontophoretically enhancing the in vitro transdermal flux of two polypeptides: leuprolide (a LHRH analogue; MW = 1209.4) and a cholecystokinin‐8 analogue (CCK‐8; MW = 1150.17). Control experiments at an applied voltage of 0.5 V across full‐thickness human skin did not yield measurable fluxes of either polypeptide, suggesting that despite the expected iontophoretic flux enhancements, the intrinsic permeability of these polypeptides through skin may be too low to allow significant amounts of the drug to permeate. Therefore, pretreatment with ethanol (to simulate the effect of a chemical permeation enhancer) followed by iontophoresis was investigated with the aim of evaluating the potential of the enhancer plus iontophoresis as a means for controlled transdermal delivery of these polypeptides. The ethanol pretreatment dramatically increased the passive fluxes of both polypeptides, and iontophoresis produced further enhancements in their fluxes. Also, the experimental enhancement factors for leuprolide as a function of the applied voltage appeared to be generally lower than the predictions of the constant field theory. A synergism of iontophoresis with a chemical permeation enhancer may be a potential route for controlled transdermal delivery of these and other high molecular weight polypeptides. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:588 / 591
页数:4
相关论文
共 15 条
[1]   NASAL ABSORPTION OF NAFARELIN ACETATE, THE DECAPEPTIDE [D-NAL(2)6]LHRH, IN RHESUS-MONKEYS .1. [J].
ANIK, ST ;
MCRAE, G ;
NERENBERG, C ;
WORDEN, A ;
FOREMAN, J ;
HWANG, JY ;
KUSHINSKY, S ;
JONES, RE ;
VICKERY, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (05) :684-685
[2]  
[Anonymous], 1954, Z PHYS CHEM, DOI DOI 10.1524/ZPCH.1954.1.5_6.305
[3]   IONTOPHORETIC DELIVERY OF DRUGS - FUNDAMENTALS, DEVELOPMENTS AND BIOMEDICAL APPLICATIONS [J].
BANGA, AK ;
CHIEN, YW .
JOURNAL OF CONTROLLED RELEASE, 1988, 7 (01) :1-24
[4]   Potential, impedance, and rectification in membranes [J].
Goldman, DE .
JOURNAL OF GENERAL PHYSIOLOGY, 1943, 27 (01) :37-60
[5]   APPLICATION OF ELECTRODIFFUSION THEORY FOR A HOMOGENEOUS MEMBRANE TO IONTOPHORETIC TRANSPORT THROUGH SKIN [J].
KASTING, GB ;
KEISTER, JC .
JOURNAL OF CONTROLLED RELEASE, 1989, 8 (03) :195-210
[6]   AN INVITRO METHOD FOR STUDYING THE IONTOPHORETIC ENHANCEMENT OF DRUG TRANSPORT THROUGH SKIN [J].
KASTING, GB ;
MERRITT, EW ;
KEISTER, JC .
JOURNAL OF MEMBRANE SCIENCE, 1988, 35 (02) :137-159
[7]   IONIC MASS-TRANSPORT THROUGH A HOMOGENEOUS MEMBRANE IN THE PRESENCE OF A UNIFORM ELECTRIC-FIELD [J].
KEISTER, JC ;
KASTING, GB .
JOURNAL OF MEMBRANE SCIENCE, 1986, 29 (02) :155-167
[8]  
MARTIN EW, 1965, REMINGTONS PHARM SCI, P1506
[9]   EXAMINATION OF IONTOPHORETIC TRANSPORT OF IONIC DRUGS ACROSS SKIN - BASELINE STUDIES WITH THE 4-ELECTRODE SYSTEM [J].
MASADA, T ;
HIGUCHI, WI ;
SRINIVASAN, V ;
ROHR, U ;
FOX, J ;
BEHL, C ;
PONS, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (01) :57-62
[10]   PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF POLYPEPTIDE DELIVERY [J].
MAZER, NA .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :343-356